Table 3 Recurrence patterns of PR + and PR- cohorts.

From: The role of adjuvant endocrine treatment in ER+, PR−, HER2− early breast cancer: a retrospective study of real-world data

Recurrence pattern

ER+/PR + 

n = 332(%)

ER+/PR-

n = 67(%)

p-value

Relapse sites

   

Local relapse

105/332(31.6)

10/67(14.9)

0.007

Distant relapse

160/332(48.2)

44/67(65.7)

0.011

Lung

57/160(35.6)

18/44(40.9)

0.597

Liver

38/160(23.8)

14/44(31.8)

0.329

Bone

88/160(55.0)

19/44(43.2)

0.177

Brain

10/160(6.3)

9/44(20.5)

0.010

Other sites

21/160(13.1)

8/44(18.2)

0.464

Secondary cancer

53/332(16.0)

11/67(16.4)

1.000

Other cause of death

16/332(4.8)

3/67(4.8)

1.000